StreetInsider.com News Articles

Cresco Labs Delivers Q4 2025 Revenue of $162 Million and Sequential Margin Improvement

Thu, 05 Mar 2026 06:30:00 -0500

CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the fourth quarter ended and year ended December 31, 2025. All financial information presented in this release is reported in accordance with U.S. GAAP and in U.S. dollars, unless otherwise indicated, and is available on the Company’s investor website, here.

Fiscal Year 2025 Highlights

Revenue of $656 million. Operating

Cresco Labs Delivers Q4 2025 Revenue of $162 Million and Sequential Margin Improvement

Thu, 05 Mar 2026 06:30:00 -0500

Fiscal Year 2025 Highlights

Revenue of $656 million. Operating

Cresco Labs Delivers Q4 2025 Revenue of $162 Million and Sequential Margin Improvement

Thu, 05 Mar 2026 06:30:00 -0500

Fiscal Year 2025 Highlights

Revenue of $656 million. Operating

Cresco Labs Delivers Q4 2025 Revenue of $162 Million and Sequential Margin Improvement

Thu, 05 Mar 2026 06:30:00 -0500

Fiscal Year 2025 Highlights

Revenue of $656 million. Operating

Cresco Labs Delivers Q4 2025 Revenue of $162 Million and Sequential Margin Improvement

Thu, 05 Mar 2026 06:30:00 -0500

Fiscal Year 2025 Highlights

Revenue of $656 million. Operating

Cresco Labs Delivers Q4 2025 Revenue of $162 Million and Sequential Margin Improvement

Thu, 05 Mar 2026 06:30:00 -0500

Fiscal Year 2025 Highlights

Revenue of $656 million. Operating

Cresco Labs Delivers Q4 2025 Revenue of $162 Million and Sequential Margin Improvement

Thu, 05 Mar 2026 06:30:00 -0500

Fiscal Year 2025 Highlights

Revenue of $656 million. Operating

Cresco Labs Delivers Q4 2025 Revenue of $162 Million and Sequential Margin Improvement

Thu, 05 Mar 2026 06:30:00 -0500

Fiscal Year 2025 Highlights

Revenue of $656 million. Operating

Cresco Labs Delivers Q4 2025 Revenue of $162 Million and Sequential Margin Improvement

Thu, 05 Mar 2026 06:30:00 -0500

Fiscal Year 2025 Highlights

Revenue of $656 million. Operating

Cresco Labs Delivers Q4 2025 Revenue of $162 Million and Sequential Margin Improvement

Thu, 05 Mar 2026 06:30:00 -0500

Fiscal Year 2025 Highlights

Revenue of $656 million. Operating

Cresco Labs to Report Fourth Quarter 2025 Financial Results on March 5, 2026

Mon, 23 Feb 2026 06:30:00 -0500

CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the full year and quarter ended December 31st, 2025 on Thursday, March 5, 2026 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.

Event: Cresco Labs Fourth Quarter 2025 Earnings Conference Call
Date: Thursday, March 5, 2026

Cresco Labs to Report Fourth Quarter 2025 Financial Results on March 5, 2026

Mon, 23 Feb 2026 06:30:00 -0500

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.

Event: Cresco Labs Fourth Quarter 2025 Earnings Conference Call
Date: Thursday, March 5, 2026

Cresco Labs to Report Fourth Quarter 2025 Financial Results on March 5, 2026

Mon, 23 Feb 2026 06:30:00 -0500

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.

Event: Cresco Labs Fourth Quarter 2025 Earnings Conference Call
Date: Thursday, March 5, 2026

Cresco Labs to Report Fourth Quarter 2025 Financial Results on March 5, 2026

Mon, 23 Feb 2026 06:30:00 -0500

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.

Event: Cresco Labs Fourth Quarter 2025 Earnings Conference Call
Date: Thursday, March 5, 2026

Cresco Labs to Report Fourth Quarter 2025 Financial Results on March 5, 2026

Mon, 23 Feb 2026 06:30:00 -0500

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.

Event: Cresco Labs Fourth Quarter 2025 Earnings Conference Call
Date: Thursday, March 5, 2026

Cresco Labs to Report Fourth Quarter 2025 Financial Results on March 5, 2026

Mon, 23 Feb 2026 06:30:00 -0500

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.

Event: Cresco Labs Fourth Quarter 2025 Earnings Conference Call
Date: Thursday, March 5, 2026

Cresco Labs to Report Fourth Quarter 2025 Financial Results on March 5, 2026

Mon, 23 Feb 2026 06:30:00 -0500

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.

Event: Cresco Labs Fourth Quarter 2025 Earnings Conference Call
Date: Thursday, March 5, 2026

Cresco Labs to Report Fourth Quarter 2025 Financial Results on March 5, 2026

Mon, 23 Feb 2026 06:30:00 -0500

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.

Event: Cresco Labs Fourth Quarter 2025 Earnings Conference Call
Date: Thursday, March 5, 2026

Cresco Labs to Report Fourth Quarter 2025 Financial Results on March 5, 2026

Mon, 23 Feb 2026 06:30:00 -0500

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.

Event: Cresco Labs Fourth Quarter 2025 Earnings Conference Call
Date: Thursday, March 5, 2026

Cresco Labs to Report Fourth Quarter 2025 Financial Results on March 5, 2026

Mon, 23 Feb 2026 06:30:00 -0500

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.

Event: Cresco Labs Fourth Quarter 2025 Earnings Conference Call
Date: Thursday, March 5, 2026

Cresco Labs Establishes At-the-Market Offering

Fri, 30 Jan 2026 06:30:00 -0500

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN OR INTO THE UNITED STATES

CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it has entered into an equity distribution agreement (the “Equity Distribution Agreement“) with Haywood Securities Inc. pursuant to which the Company may, from time to time, sell up to approximately US$100 million (C$140 million) of subordinate voting shares (“Subordinate Voting Shares“) in

Cresco Labs Establishes At-the-Market Offering

Fri, 30 Jan 2026 06:30:00 -0500

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN OR INTO THE UNITED STATES

CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it has entered into an equity distribution agreement (the “Equity Distribution Agreement“) with Haywood Securities Inc. pursuant to which the Company may, from time to time, sell up to approximately US$100 million (C$140 million) of subordinate voting shares (“Subordinate Voting Shares“) in

Cresco Labs Establishes At-the-Market Offering

Fri, 30 Jan 2026 06:30:00 -0500

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN OR INTO THE UNITED STATES

CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it has entered into an equity distribution agreement (the “Equity Distribution Agreement“) with Haywood Securities Inc. pursuant to which the Company may, from time to time, sell up to approximately US$100 million (C$140 million) of subordinate voting shares (“Subordinate Voting Shares“) in

Cresco Labs Establishes At-the-Market Offering

Fri, 30 Jan 2026 06:30:00 -0500

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN OR INTO THE UNITED STATES

CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it has entered into an equity distribution agreement (the “Equity Distribution Agreement“) with Haywood Securities Inc. pursuant to which the Company may, from time to time, sell up to approximately US$100 million (C$140 million) of subordinate voting shares (“Subordinate Voting Shares“) in

Cresco Labs Establishes At-the-Market Offering

Fri, 30 Jan 2026 06:30:00 -0500

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN OR INTO THE UNITED STATES

CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it has entered into an equity distribution agreement (the “Equity Distribution Agreement“) with Haywood Securities Inc. pursuant to which the Company may, from time to time, sell up to approximately US$100 million (C$140 million) of subordinate voting shares (“Subordinate Voting Shares“) in